A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With Osteoporosis
Clinical trial NCT05067335 · COMPLETED
Trial details
- NCT number
- NCT05067335
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-21
- Primary completion
- 2023-11-09
- Enrollment
- 327
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.